Sangi, Diego P.; Cominetti, Márcia Regina; Becceneri, Amanda B.; Resende, Flavia A.; Varanda, Eliana Aparecida; Montanari, Carlos Alberto 
; Paixão, Márcio Weber; Corrêa, Arlene Gonçalves
Fonte: Medicinal Chemistry. Unidade: IQSC
Assuntos: QUÍMICA MÉDICA, ESTRÓGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANGI, Diego P. et al. Molecular design, synthesis and evaluation of 2,3-diarylquinoxalines as estrogen receptor ligands. Medicinal Chemistry, v. 11, n. 8, p. 736-746, 2015Tradução . . Disponível em: https://doi.org/10.2174/1573406411666150513093039. Acesso em: 01 out. 2024.APA
Sangi, D. P., Cominetti, M. R., Becceneri, A. B., Resende, F. A., Varanda, E. A., Montanari, C. A., et al. (2015). Molecular design, synthesis and evaluation of 2,3-diarylquinoxalines as estrogen receptor ligands. Medicinal Chemistry, 11( 8), 736-746. doi:10.2174/1573406411666150513093039NLM
Sangi DP, Cominetti MR, Becceneri AB, Resende FA, Varanda EA, Montanari CA, Paixão MW, Corrêa AG. Molecular design, synthesis and evaluation of 2,3-diarylquinoxalines as estrogen receptor ligands [Internet]. Medicinal Chemistry. 2015 ; 11( 8): 736-746.[citado 2024 out. 01 ] Available from: https://doi.org/10.2174/1573406411666150513093039Vancouver
Sangi DP, Cominetti MR, Becceneri AB, Resende FA, Varanda EA, Montanari CA, Paixão MW, Corrêa AG. Molecular design, synthesis and evaluation of 2,3-diarylquinoxalines as estrogen receptor ligands [Internet]. Medicinal Chemistry. 2015 ; 11( 8): 736-746.[citado 2024 out. 01 ] Available from: https://doi.org/10.2174/1573406411666150513093039
